DK1891075T3 - Tricykliske spiroderivater som CRTH2-modulatorer - Google Patents
Tricykliske spiroderivater som CRTH2-modulatorerInfo
- Publication number
- DK1891075T3 DK1891075T3 DK06763238.0T DK06763238T DK1891075T3 DK 1891075 T3 DK1891075 T3 DK 1891075T3 DK 06763238 T DK06763238 T DK 06763238T DK 1891075 T3 DK1891075 T3 DK 1891075T3
- Authority
- DK
- Denmark
- Prior art keywords
- spiro derivatives
- tricyclic spiro
- crth2 modulators
- crth2
- modulators
- Prior art date
Links
- 102000009389 Prostaglandin D receptors Human genes 0.000 title 1
- 108050000258 Prostaglandin D receptors Proteins 0.000 title 1
- 125000003003 spiro group Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05104428 | 2005-05-24 | ||
| US68863105P | 2005-06-08 | 2005-06-08 | |
| PCT/EP2006/062545 WO2006125784A1 (en) | 2005-05-24 | 2006-05-23 | Tricyclic spiro derivatives as crth2 modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1891075T3 true DK1891075T3 (da) | 2011-12-19 |
Family
ID=35478408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06763238.0T DK1891075T3 (da) | 2005-05-24 | 2006-05-23 | Tricykliske spiroderivater som CRTH2-modulatorer |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8236963B2 (https=) |
| EP (1) | EP1891075B1 (https=) |
| JP (1) | JP5567268B2 (https=) |
| KR (1) | KR101333861B1 (https=) |
| CN (1) | CN101300259B (https=) |
| AR (1) | AR055959A1 (https=) |
| AT (1) | ATE529429T1 (https=) |
| AU (1) | AU2006251138C1 (https=) |
| BR (1) | BRPI0610209A2 (https=) |
| CA (1) | CA2602965C (https=) |
| DK (1) | DK1891075T3 (https=) |
| ES (1) | ES2375614T3 (https=) |
| MX (1) | MX2007014256A (https=) |
| NZ (1) | NZ562772A (https=) |
| PL (1) | PL1891075T3 (https=) |
| PT (1) | PT1891075E (https=) |
| RU (1) | RU2478639C2 (https=) |
| UA (1) | UA90145C2 (https=) |
| WO (1) | WO2006125784A1 (https=) |
| ZA (1) | ZA200709819B (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0715179A2 (pt) | 2006-08-07 | 2013-06-11 | Actelion Pharmaceuticals Ltd | composto, composiÇço farmacÊutica e uso de um composto |
| US20120115895A1 (en) | 2009-07-15 | 2012-05-10 | Merck Serono S.A. | Tricyclic indole-derived spiro derivatives as crth2 modulators |
| KR20120099462A (ko) | 2009-11-12 | 2012-09-10 | 더 리젠츠 오브 더 유니버시티 오브 미시건 | 스피로-옥신돌 ｍｄｍ2 길항제 |
| PT2558447E (pt) | 2010-03-22 | 2014-11-25 | Actelion Pharmaceuticals Ltd | Derivados de 3-(heteroarilamino)-1,2,3,4-tetrahidro-9hcarbazol e o seu uso como moduladores do receptor de prostaglandina d2 |
| AU2011326395B2 (en) | 2010-11-12 | 2016-01-07 | Ascenta Licensing Corporation | Spiro-oxindole MDM2 antagonists |
| EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
| DK2697223T3 (en) | 2011-04-14 | 2016-09-05 | Actelion Pharmaceuticals Ltd | 7- (heteroaryl-amino) -6,7,8,9-tetrahydro-pyrido [1,2-a] indole-acetic acid derivatives and their use as prostaglandin D2 receptor |
| US8629141B2 (en) | 2011-05-11 | 2014-01-14 | The Regents Of The University Of Michigan | Spiro-oxindole MDM2 antagonists |
| EP2790696A1 (en) | 2011-12-16 | 2014-10-22 | Atopix Therapeutics Limited | Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis |
| CN103554118B (zh) * | 2013-10-15 | 2015-08-19 | 华东师范大学 | 四氢呋喃并苯并二氢吡喃多环化合物及其应用 |
| CN103554119B (zh) * | 2013-10-15 | 2015-09-16 | 华东师范大学 | 四氢呋喃并苯并二氢吡喃多环化合物的制备方法 |
| CN103554120B (zh) * | 2013-10-16 | 2015-06-24 | 华东师范大学 | 3,3-螺(2-四氢呋喃)氧化吲哚多环状化合物的制备方法 |
| CN103554121B (zh) * | 2013-10-16 | 2015-06-24 | 华东师范大学 | 3,3-螺(2-四氢呋喃)氧化吲哚多环状化合物及其应用 |
| AR099767A1 (es) | 2014-03-17 | 2016-08-17 | Actelion Pharmaceuticals Ltd | Derivados del ácido acético azaindol y su uso como moduladores del receptor de prostaglandina d2 |
| KR20160133536A (ko) | 2014-03-18 | 2016-11-22 | 액테리온 파마슈티칼 리미티드 | 아자인돌 아세트산 유도체 및 프로스타글란딘 d2 수용체 조절제로서의 이의 용도 |
| US9745253B2 (en) | 2015-03-13 | 2017-08-29 | Forma Therapeutics, Inc. | Alpha-cinnamide compounds and compositions as HDAC8 inhibitors |
| ES2733468T3 (es) | 2015-07-15 | 2019-11-29 | Hoffmann La Roche | Derivados de etinilo como moduladores de los receptores metabotrópicos de glutamato |
| AU2016323262B2 (en) | 2015-09-15 | 2020-11-19 | Idorsia Pharmaceuticals Ltd | Crystalline forms |
| RU2631856C1 (ru) * | 2016-05-04 | 2017-09-27 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Чувашский государственный университет имени И.Н. Ульянова" | Способ получения аммонийных солей 3-амино-8-гидрокси-1,6-диоксо-4-циано-2,7-диазаспиро[4.4]нон-3-ен-2-идов |
| WO2018015235A1 (en) | 2016-07-18 | 2018-01-25 | F. Hoffmann-La Roche Ag | Ethynyl derivatives |
| CN109384787B (zh) * | 2017-08-08 | 2021-04-16 | 沈阳药科大学 | 一种一价银催化的氢化吡啶螺二氢吲哚环的合成方法 |
| CN109384794B (zh) * | 2017-08-08 | 2020-06-19 | 沈阳药科大学 | 质子酸催化的一类四环吲哚骨架的合成方法 |
| CN109369658B (zh) * | 2017-08-08 | 2020-01-31 | 沈阳药科大学 | 一种螺[吡咯烷-3,3`-氧化吲哚]环系的合成方法 |
| KR101857408B1 (ko) | 2018-02-28 | 2018-05-14 | 경북대학교 산학협력단 | 탈모 예방 또는 치료용 조성물 |
| EP3902805A4 (en) | 2018-12-28 | 2023-03-01 | SPV Therapeutics Inc. | CYCLINE-DEPENDENT KINASE INHIBITORS |
| CN112876488B (zh) * | 2021-02-18 | 2021-12-21 | 苏州大学 | 螺环吲哚啉衍生物及其制备方法和应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52879B1 (en) * | 1981-05-12 | 1988-03-30 | Ici Plc | Pharmaceutical spiro-hydantoin derivatives |
| IE53102B1 (en) | 1981-05-12 | 1988-06-22 | Ici Plc | Pharmaceutical spiro-succinimide derivatives |
| US5948807A (en) * | 1997-09-03 | 1999-09-07 | Regents Of The University Of Minnesota | Spiroindanamines and Spiroindanimides |
| NZ528846A (en) * | 1999-03-12 | 2005-05-27 | Boehringer Ingelheim Pharma | Compounds useful as anti-inflammatory agents |
| SE0200411D0 (sv) * | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| SE0200356D0 (sv) * | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| GB2388540A (en) | 2002-05-17 | 2003-11-19 | Bayer Ag | New use of Ramatroban |
| AU2003277285B2 (en) | 2002-10-04 | 2007-12-13 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
| EP1556356B1 (en) | 2002-10-21 | 2006-05-31 | Warner-Lambert Company LLC | Tetrahydroquinoline derivatives as crth2 antagonists |
| DE60303238T2 (de) | 2003-04-25 | 2006-09-14 | Actimis Pharmaceuticals, Inc., La Jolla | Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten |
| SE0301569D0 (sv) | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
| SE0301650D0 (sv) | 2003-06-04 | 2003-06-04 | Astrazeneca Ab | Novel compounds |
| SE0301653D0 (sv) | 2003-06-05 | 2003-06-05 | Astrazeneca Ab | Novel compounds |
| US20050038070A1 (en) | 2003-07-09 | 2005-02-17 | Amgen Inc. | Asthma and allergic inflammation modulators |
| MXPA06011891A (es) | 2004-04-20 | 2007-04-24 | Pfizer | Metodo para tratar el dolor neuropatico. |
-
2006
- 2006-05-23 NZ NZ562772A patent/NZ562772A/en not_active IP Right Cessation
- 2006-05-23 AT AT06763238T patent/ATE529429T1/de active
- 2006-05-23 AU AU2006251138A patent/AU2006251138C1/en not_active Ceased
- 2006-05-23 DK DK06763238.0T patent/DK1891075T3/da active
- 2006-05-23 EP EP06763238A patent/EP1891075B1/en active Active
- 2006-05-23 CN CN2006800266403A patent/CN101300259B/zh not_active Expired - Fee Related
- 2006-05-23 US US11/919,471 patent/US8236963B2/en not_active Expired - Fee Related
- 2006-05-23 ES ES06763238T patent/ES2375614T3/es active Active
- 2006-05-23 RU RU2007147430/04A patent/RU2478639C2/ru not_active IP Right Cessation
- 2006-05-23 PL PL06763238T patent/PL1891075T3/pl unknown
- 2006-05-23 ZA ZA200709819A patent/ZA200709819B/xx unknown
- 2006-05-23 CA CA2602965A patent/CA2602965C/en not_active Expired - Fee Related
- 2006-05-23 WO PCT/EP2006/062545 patent/WO2006125784A1/en not_active Ceased
- 2006-05-23 BR BRPI0610209-3A patent/BRPI0610209A2/pt not_active IP Right Cessation
- 2006-05-23 PT PT06763238T patent/PT1891075E/pt unknown
- 2006-05-23 MX MX2007014256A patent/MX2007014256A/es active IP Right Grant
- 2006-05-23 UA UAA200713923A patent/UA90145C2/ru unknown
- 2006-05-23 KR KR1020077029797A patent/KR101333861B1/ko not_active Expired - Fee Related
- 2006-05-23 JP JP2008512832A patent/JP5567268B2/ja not_active Expired - Fee Related
- 2006-05-24 AR ARP060102148A patent/AR055959A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1891075A1 (en) | 2008-02-27 |
| ES2375614T3 (es) | 2012-03-02 |
| JP2008542238A (ja) | 2008-11-27 |
| JP5567268B2 (ja) | 2014-08-06 |
| RU2007147430A (ru) | 2009-06-27 |
| CN101300259B (zh) | 2013-08-28 |
| AU2006251138A1 (en) | 2006-11-30 |
| ATE529429T1 (de) | 2011-11-15 |
| AU2006251138C1 (en) | 2013-08-29 |
| NZ562772A (en) | 2010-01-29 |
| UA90145C2 (ru) | 2010-04-12 |
| AR055959A1 (es) | 2007-09-12 |
| RU2478639C2 (ru) | 2013-04-10 |
| CA2602965C (en) | 2013-12-31 |
| US8236963B2 (en) | 2012-08-07 |
| BRPI0610209A2 (pt) | 2010-06-01 |
| US20090318486A1 (en) | 2009-12-24 |
| PL1891075T3 (pl) | 2011-12-30 |
| KR101333861B1 (ko) | 2013-11-28 |
| PT1891075E (pt) | 2011-11-10 |
| ZA200709819B (en) | 2009-09-30 |
| MX2007014256A (es) | 2008-03-26 |
| CN101300259A (zh) | 2008-11-05 |
| CA2602965A1 (en) | 2006-11-30 |
| EP1891075B1 (en) | 2011-10-19 |
| KR20080031191A (ko) | 2008-04-08 |
| AU2006251138B2 (en) | 2012-08-09 |
| WO2006125784A1 (en) | 2006-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1891075T3 (da) | Tricykliske spiroderivater som CRTH2-modulatorer | |
| DK2069335T3 (da) | Pyridin-3-ylderivater som immunomoduleringsmidler | |
| ATE510831T1 (de) | Hydrierte benzoäcüthiophenderivate als immunmodulatoren | |
| DK2069336T3 (da) | Pyridin-4-yl-derivater som immunomodulerende midler | |
| DK1928845T3 (da) | Aminodiazepiner som toll-lignende receptor-modulatorer | |
| DK2144897T3 (da) | 8-Oxy-quinolinderivater som bradykinin B2-receptormodulatorer | |
| DK1756096T3 (da) | Indolylderivater som lever-X-receptormodulatorer | |
| DK1940797T3 (da) | 8-substituerede benzodiazepiner som toll-like receptor- modulatorer | |
| DK1863818T3 (da) | Acetylenyl-pyrazolo-pyrimidinderivater som mglur2-antagonister | |
| NO20070494L (no) | Substituerte azepinderivater som serotoninreseptormodulatorer | |
| DK2094658T3 (da) | Tetrahydrocyclopenta[B]indolforbindelser som androgenreceptormodulatorer | |
| DK1735286T3 (da) | Tetrahydroindazoler som cannabinoidmodulatorer | |
| DK2176220T3 (da) | Pyrrolidin-2-on-derivater som androgenreceptormodulatorer. | |
| DK2125827T3 (da) | Azaspiroderivater | |
| BRPI0823082A2 (pt) | Uso derivados de sesquiterpeno | |
| EP2097384A4 (en) | INDOZALYL SULFOMNAMIDE DERIVATIVES USEFUL AS MODULATORS OF GLUCOCORTICOIDS | |
| IL180977A0 (en) | Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators | |
| EP1841794A4 (en) | MODULATORS ADAM-9 | |
| NO344044B1 (no) | Nye triazindionderivater som GABA-B-reseptormodulatorer | |
| DK2252609T3 (da) | Pyridin-2-yl-derivater som immunomodulerende midler | |
| ATE469899T1 (de) | Spiropiperidinderivate | |
| ATE490251T1 (de) | Tricyclische opioidmodulatoren | |
| DK1809624T3 (da) | Pyrimidinsulfonamidderivater som kemokinreceptor-modulatorer | |
| DK2114888T3 (da) | Tricykliske forbindelser og deres anvendelse som glu-cocorticoid-receptor-modulatorer | |
| EP1915162A4 (en) | Modulators |